A 

Why do we need a

    PneumoADIP?

What is GAVI?

What are GAVI’s objectives?

What is the Vaccine Fund?

What is Johns Hopkins

     Bloomberg School of

     Public Health?

PneumoADIP Sponsored

     Projects

PNEUMOADIP MISSION

The Pneumococcal Vaccines Accelerated Development and Introduction Plan is an independent group located at Johns Hopkins and funded by GAVI. Our mission is to improve child health by accelerating the evaluation of and access to, new life saving pneumococcal vaccines for the world’s poorest children.

PNEUMOADIP (PNEUMOCOCCAL VACCINES

ACCELERATED DEVELOPMENT & INTRODUCTION PLAN) next    

The Pneumococcal Vaccines Accelerated Development and Introduction Plan (PneumoADIP) is a project located at the Johns Hopkins Bloomberg School of Public Health and funded by an award of $30 million from the Global Alliance for Vaccines and Immunization (GAVI) and its partner, the Vaccine Fund (VF).

The PneumoADIP is an innovative effort to achieve a global health objective that has never been met before – assuring the earliest access to new life-saving vaccines for the world’s poorest children., The PneumoADIP aims to achieve this ambitious goal by sharing risks with the private sector and in return obtaining a more sustainable, affordable supply of vaccine for the world’s poorest countries. The PneumoADIP team is small and composed of 6 dedicated professionals funded by an award from GAVI. It is housed at the Johns Hopkins Bloomberg School of Public Health— a leading global health research institution that provides flexibility and support.

next

top

contact us | privacy statement | disclaimer | copyright 2004 jhsph